SURF-100

mycophenolic acid and betamethone sodium phosphate · Surface Ophthalmics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SURF-100, covering 2025-03-18 to 2025-03-18. Get the full timeline:

Most recent: Clinical Trial Update: A Research Study To See How Well an Eye Drop, SURF-100 (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination), Works and What Side Effects There Are in Subjects With Dry Eye Disease [Phase 2]

See pricing